It’s true that a former   post-doctoral fellow at Johns Hopkins University questioned the safety   and effectiveness of flu vaccines in a scholarly article, but that view   isn’t widely accepted in the epidemiology field. Peter Doshi was a post-doctoral fellow at Johns Hopkins University   School of Medicine when he published an   article in the   British Medical Journal in May 2013 titled “Influenza: Marketing Vaccine   by Marketing Disease.” Doshi argued in the article that flu vaccines   could be less beneficial and less safe than once believed, and that the   Centers for Disease Control and Prevention (CDC) has overstated the   threat of influenza. After his fellowship ended, Doshi became an   assistant professor of pharmaceutical health services at the University   of Maryland School of Pharmacy, according to the school’s   website. Doshi’s article gained widespread attention when the   website Newsmax Health   reported on it in May 2013. Still, Doshi’s views   are not widely accepted in the epidemiology field. In fact, Johns Hopkins University   requires that its medical staff receive flu vaccinations each fall. The school’s   website says the policy is for “the safety of our patients, trainees,   staff, faculty, physicians and students.”   Posted  10/23/14    Comments
 Reports have gone viral that a   scientist from Johns Hopkins University said flu vaccines aren’t as   effective as once thought and that studies used to promote widespread   vaccines are often low quality.      